BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
7.98
+0.30 (3.87%)
Oct 30, 2025, 8:00 AM EDT - Market open
BioAge Labs Market Cap
BioAge Labs has a market cap or net worth of $285.99 million as of October 30, 2025. Its market cap has decreased by -63.20% in one year.
Market Cap
285.99M
Enterprise Value
-29.33M
1-Year Change
-63.20%
Ranking
Category
Stock Price
$7.98
Market Cap Chart
Since the IPO on September 26, 2024, BioAge Labs's market cap has decreased from $615.01M to $285.99M, a decrease of -53.50%. That is a compound annual growth rate of -50.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 282.86M | 36.27% |
| Dec 31, 2024 | 207.56M | -66.25% |
| Sep 26, 2024 | 615.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.27B |
| Johnson & Johnson | 449.41B |
| AbbVie | 397.74B |
| UnitedHealth Group | 321.64B |
| AstraZeneca | 257.84B |
| Novartis AG | 239.27B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.53B |